Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine vs Gemcitabine + Cisplatin in the Treatment of Advanced Pancreatic Cancer (Stage II III IV)

NCT00813696 is registered in ClinicalTrials.gov with Istituti Tumori Giovanni Paolo II as lead sponsor.

NCT NCT00813696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00813696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine vs Gemcitabine + Cisplatin in the Treatment of Advanced Pancreatic Cancer (Stage II III IV)
Lead sponsor
Istituti Tumori Giovanni Paolo II
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2002
Completion date
September 30, 2009
Enrollment
400 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer